SCHEMBL6237136

SCHEMBL6237136

COCCOc1ccc(-c2cnc3nc(-c4cccs4)c(-c4cccs4)nc3c2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RPS6KB2 Q9UBS0 4/20 0.44
ALDH1A1 P00352 11/20 0.41
CYP1A2 P05177 10/20 0.41
CASP1 P29466 10/20 0.41
CASP7 P55210 10/20 0.41
HSD17B10 Q99714 9/20 0.41
CYP3A4 P08684 9/20 0.41
MEN1 O00255 6/20 0.41
KMT2A Q03164 6/20 0.41
CYP2C9 P11712 5/20 0.41
CYP2C19 P33261 5/20 0.41
MAPK1 P28482 4/20 0.41
GLA P06280 3/20 0.41
KDM4E B2RXH2 2/20 0.41
CLK4 Q9HAZ1 1/20 0.41
LMNA P02545 1/20 0.41
MAPT P10636 1/20 0.41
HIF1A Q16665 7/20 0.41
USP2 O75604 6/20 0.41
HPGD P15428 5/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6240919 0.95 RPS6KB2 (0.44) RPS6KB2ALDH1A1CYP1A2CASP1CASP7
SCHEMBL6234238 0.90 RPS6KB2 (0.44) RPS6KB2ALDH1A1CYP1A2CASP1CASP7
SCHEMBL6233813 0.88 RPS6KB2 (0.43) RPS6KB2ALDH1A1CYP1A2CASP1CASP7
SCHEMBL6261584 0.88 RPS6KB2 (0.41) RPS6KB2ALDH1A1CYP1A2CASP1CASP7
SCHEMBL6235648 0.88 HRH3 (0.51) ALDH1A1CYP1A2CASP1CASP7HSD17B10
SCHEMBL6255922 0.80 HRH3 (0.51) ALDH1A1CYP1A2MAPK1LMNAUSP2
SCHEMBL6234869 0.79 HRH3 (0.48) MAPK1NPC1RAB9A
SCHEMBL6237798 0.79 RPS6KB2 (0.52) RPS6KB2MAPTSMN1; SMN2NPC1PDGFRB
SCHEMBL6256213 0.79 RPS6KB2 (0.60) RPS6KB2ALDH1A1HSD17B10MEN1KMT2A
SCHEMBL6237105 0.79 RPS6KB2 (0.49) RPS6KB2ALDH1A1CYP1A2CASP1CASP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005007099-A2 PKB INHIBITORS AS ANTI-TUMOR AGENTS IMCLONE SYSTEMS INCORPORATED (US) 2005-01-27 WO disclosed